Artificial Insemination (AI) is a fertility assisted reproductive technique used mainly for women who cannot conceive through natural conception. It involves placing sperm close to egg to facilitate fertilization. AI products include intrauterine insemination and intracervical insemination kits which do not require surgery. These kits contain all necessary equipment needed for at-home AI including sperm straw or vials, catheter, syringe and collection devices. The AI kits are affordable and easy to use for personal and private insemination. The global AI market is also gaining traction owing to increasing male infertility and rising fertility awareness.
The global Artificial Insemination Market is estimated to be valued at US$ 9.2 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the artificial insemination market is the increasing adoption of fertility tourism. Fertility tourism involves traveling abroad for fertility treatments and assisted reproductive technologies including IVF and artificial insemination that are more accessible in terms of cost and availability. This is allowing individuals from regions with limited access to infertility services to seek more affordable treatment options abroad, thereby boosting the overall AI market growth. Another notable trend fuelling the market is the rising popularity of home insemination kits. These kits provide privacy and discretion for self-administered insemination without involving clinicians or fertility specialists. The home kits market segment is witnessing robust demand especially post-COVID-19 pandemic owing to its convenience and safety aspects.
Porter’s Analysis
Threat of new entrants: Low as artificial insemination market requires highly skilled manpower and technological setup which is a barrier for new players.
Bargaining power of buyers: Moderate as artificial insemination treatments are usually not covered under medical insurance and there are alternatives available to consumers like in-vitro fertilization and surrogacy.
Bargaining power of suppliers: Moderate as major players provide proprietary technologies and skilled workforce. Suppliers have differentiation but market has alternatives.
Threat of new substitutes: High as technologies like in-vitro fertilization and egg/sperm donation are developing as substitutes with better success rates.
Competitive rivalry: Intense competition among major players to provide differentiated offerings and proprietary technologies.
Key Takeaways
The Global Artificial Insemination Market Size is expected to witness high growth over the forecast period.
Regional analysis: North America is projected to dominate the global artificial insemination market during the forecast period. This is attributed to growing awareness regarding Artificial Insemination and assisted reproductive technologies acceptance, increasing prevalence of infertility and delayed pregnancies.
Key players: Key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.